Childhood refractory autoimmune haemolytic anaemia: Is there a role for anti-CD20 therapy (rituximab)?

被引：15

作者：

Mc Mahon, C ^{[1
]}

Babu, L ^{[1
]}

Hodgson, A ^{[1
]}

Hayat, A ^{[1
]}

Connell, NO ^{[1
]}

Smith, OP ^{[1
]}

机构：

[1] AMNCH, Dept Paediat Haematol, Dublin, Ireland

来源：

关键词：

childhood; AIHA; immunosuppression; B-lymphocytes; rituximab;

D O I：

10.1046/j.1365-2141.2002.03422_2.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：480 / 482

页数：3

共 6 条

[1]

Ahrens N, 2001, BRIT J HAEMATOL, V114, P244

[2] Rituxan in the treatment of cold agglutinin disease [J].

Lee, EJ ;

Kueck, B .

[3] Rituximab [J].

Onrust, SV ;

Lamb, HM ;

Balfour, JAB .

[4]

RAI KR, 2000, BLOOD, V96, pA596

[5]

WILEY JM, 2001, J PEDIAT HEMATOLOGY, V23, pA12

Zecca, M ;

De Stefano, P ;

Nobili, B ;

Locatelli, F .